nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—Airway obstruction NOS—Hydrochlorothiazide—nephrolithiasis	0.305	0.401	CcSEcCtD
Ketamine—Obstructive airways disorder—Hydrochlorothiazide—nephrolithiasis	0.221	0.29	CcSEcCtD
Ketamine—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0256	0.0337	CcSEcCtD
Ketamine—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0225	0.0295	CcSEcCtD
Ketamine—Erythema—Hydrochlorothiazide—nephrolithiasis	0.0219	0.0288	CcSEcCtD
Ketamine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.0206	0.0271	CcSEcCtD
Ketamine—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.0179	0.0235	CcSEcCtD
Ketamine—Shock—Hydrochlorothiazide—nephrolithiasis	0.0176	0.0231	CcSEcCtD
Ketamine—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.017	0.0224	CcSEcCtD
Ketamine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.0167	0.0219	CcSEcCtD
Ketamine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.0155	0.0204	CcSEcCtD
Ketamine—Pain—Hydrochlorothiazide—nephrolithiasis	0.0153	0.0201	CcSEcCtD
Ketamine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0149	CcSEcCtD
Ketamine—Rash—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0148	CcSEcCtD
Ketamine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0148	CcSEcCtD
Ketamine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0139	CcSEcCtD
Ketamine—TACR1—Spinal Cord Injury—AQP1—nephrolithiasis	0.00771	0.0323	CbGpPWpGaD
Ketamine—TACR1—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00667	0.0279	CbGpPWpGaD
Ketamine—DRD2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00611	0.0256	CbGpPWpGaD
Ketamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00606	0.0253	CbGpPWpGaD
Ketamine—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00597	0.025	CbGpPWpGaD
Ketamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00563	0.0236	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—AQP1—nephrolithiasis	0.00532	0.0223	CbGpPWpGaD
Ketamine—DRD2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00514	0.0215	CbGpPWpGaD
Ketamine—TACR1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00483	0.0202	CbGpPWpGaD
Ketamine—OPRD1—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00464	0.0194	CbGpPWpGaD
Ketamine—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00432	0.0181	CbGpPWpGaD
Ketamine—OPRK1—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00406	0.017	CbGpPWpGaD
Ketamine—SLC6A2—NRF2 pathway—SLC2A9—nephrolithiasis	0.00406	0.017	CbGpPWpGaD
Ketamine—SLC6A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00397	0.0166	CbGpPWpGaD
Ketamine—SLC6A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00363	0.0152	CbGpPWpGaD
Ketamine—SLC6A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00363	0.0152	CbGpPWpGaD
Ketamine—OPRM1—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00344	0.0144	CbGpPWpGaD
Ketamine—TACR1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.0032	0.0134	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00282	0.0118	CbGpPWpGaD
Ketamine—PTGS1—Biological oxidations—SLC26A1—nephrolithiasis	0.00279	0.0117	CbGpPWpGaD
Ketamine—SLC6A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00275	0.0115	CbGpPWpGaD
Ketamine—SLC6A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00275	0.0115	CbGpPWpGaD
Ketamine—DRD2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0026	0.0109	CbGpPWpGaD
Ketamine—SLC6A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00256	0.0107	CbGpPWpGaD
Ketamine—SLC6A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00256	0.0107	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—RGS14—nephrolithiasis	0.00256	0.0107	CbGpPWpGaD
Ketamine—TACR1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00243	0.0102	CbGpPWpGaD
Ketamine—SLC6A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00228	0.00954	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00226	0.00947	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00226	0.00947	CbGpPWpGaD
Ketamine—TACR1—GPCR ligand binding—PTH—nephrolithiasis	0.00223	0.00932	CbGpPWpGaD
Ketamine—CYP2B6—Biological oxidations—SLC26A1—nephrolithiasis	0.00213	0.0089	CbGpPWpGaD
Ketamine—OPRD1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0021	0.00879	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00202	0.00844	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—DGKH—nephrolithiasis	0.0019	0.00796	CbGpPWpGaD
Ketamine—GRIN1—BDNF signaling pathway—SPP1—nephrolithiasis	0.00188	0.00788	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00184	0.00772	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00184	0.00772	CbGpPWpGaD
Ketamine—OPRK1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00184	0.00771	CbGpPWpGaD
Ketamine—GRIN2B—BDNF signaling pathway—SPP1—nephrolithiasis	0.00184	0.00768	CbGpPWpGaD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.0018	0.00753	CbGpPWpGaD
Ketamine—CYP2C8—Biological oxidations—SLC26A1—nephrolithiasis	0.0018	0.00753	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—ADCY10—nephrolithiasis	0.00178	0.00744	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—DGKH—nephrolithiasis	0.00173	0.00723	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00159	0.00664	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00158	0.00661	CbGpPWpGaD
Ketamine—OPRM1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00156	0.00652	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—RGS14—nephrolithiasis	0.00151	0.00632	CbGpPWpGaD
Ketamine—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.00146	0.00613	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—RGS14—nephrolithiasis	0.00144	0.00603	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.0014	0.00585	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.0014	0.00585	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00139	0.00582	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00138	0.00576	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00137	0.00574	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00133	0.00558	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.0013	0.00544	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.0013	0.00544	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—RGS14—nephrolithiasis	0.00126	0.00529	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—PTH—nephrolithiasis	0.00126	0.00526	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—PTH—nephrolithiasis	0.00125	0.00525	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—CHRM3—nephrolithiasis	0.00125	0.00523	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—CHRM3—nephrolithiasis	0.0012	0.00503	CbGpPWpGaD
Ketamine—DRD2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00118	0.00494	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00118	0.00492	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00116	0.00485	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00116	0.00485	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—PTH—nephrolithiasis	0.00114	0.00478	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—PTH—nephrolithiasis	0.0011	0.0046	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00107	0.00448	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—RGS14—nephrolithiasis	0.00107	0.00447	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00102	0.00427	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—DGKH—nephrolithiasis	0.00102	0.00427	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00102	0.00425	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00101	0.00423	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—ADCY10—nephrolithiasis	0.001	0.00419	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000997	0.00417	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000997	0.00417	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—DGKH—nephrolithiasis	0.000973	0.00407	CbGpPWpGaD
Ketamine—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000966	0.00404	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000939	0.00393	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—PTH—nephrolithiasis	0.000929	0.00389	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000926	0.00388	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—RGS14—nephrolithiasis	0.000891	0.00373	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000888	0.00372	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—ADCY10—nephrolithiasis	0.000877	0.00367	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—DGKH—nephrolithiasis	0.000853	0.00357	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—RGS14—nephrolithiasis	0.000851	0.00356	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000812	0.0034	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000812	0.0034	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—RGS14—nephrolithiasis	0.000809	0.00339	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000794	0.00332	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000775	0.00324	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—CHRM3—nephrolithiasis	0.00077	0.00322	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—RGS14—nephrolithiasis	0.000746	0.00312	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ADCY10—nephrolithiasis	0.000742	0.0031	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CHRM3—nephrolithiasis	0.000738	0.00309	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—DGKH—nephrolithiasis	0.000721	0.00302	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—PTH—nephrolithiasis	0.000708	0.00297	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—PTH—nephrolithiasis	0.000704	0.00295	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000703	0.00294	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000679	0.00284	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—PTH—nephrolithiasis	0.000675	0.00282	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—PTH—nephrolithiasis	0.000643	0.00269	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—RGS14—nephrolithiasis	0.000631	0.00264	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—GRHPR—nephrolithiasis	0.000629	0.00263	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—PTH—nephrolithiasis	0.000621	0.0026	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000617	0.00258	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000616	0.00258	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000616	0.00258	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—DGKH—nephrolithiasis	0.000602	0.00252	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000575	0.00241	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—DGKH—nephrolithiasis	0.000575	0.00241	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000574	0.0024	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000572	0.0024	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000572	0.0024	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—PTH—nephrolithiasis	0.000564	0.00236	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ADCY10—nephrolithiasis	0.000562	0.00235	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—AGXT—nephrolithiasis	0.00056	0.00235	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—DGKH—nephrolithiasis	0.000546	0.00229	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—PTH—nephrolithiasis	0.000525	0.0022	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000521	0.00218	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00051	0.00214	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00051	0.00214	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000504	0.00211	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—DGKH—nephrolithiasis	0.000504	0.00211	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—GRHPR—nephrolithiasis	0.00048	0.00201	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—RGS14—nephrolithiasis	0.000478	0.002	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—PTH—nephrolithiasis	0.000477	0.002	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—APRT—nephrolithiasis	0.000476	0.00199	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—SLC26A1—nephrolithiasis	0.000476	0.00199	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000435	0.00182	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—AGXT—nephrolithiasis	0.000427	0.00179	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—DGKH—nephrolithiasis	0.000426	0.00178	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000426	0.00178	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CHRM3—nephrolithiasis	0.000416	0.00174	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000408	0.00171	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—GRHPR—nephrolithiasis	0.000406	0.0017	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—PTH—nephrolithiasis	0.000398	0.00167	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CHRM3—nephrolithiasis	0.000395	0.00165	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PTH—nephrolithiasis	0.00038	0.00159	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CHRM3—nephrolithiasis	0.000364	0.00153	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—APRT—nephrolithiasis	0.000363	0.00152	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—SLC26A1—nephrolithiasis	0.000363	0.00152	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—AGXT—nephrolithiasis	0.000362	0.00151	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—PTH—nephrolithiasis	0.000361	0.00151	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000354	0.00148	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—AQP1—nephrolithiasis	0.000339	0.00142	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—SPP1—nephrolithiasis	0.000339	0.00142	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PTH—nephrolithiasis	0.000333	0.00139	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.00033	0.00138	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000323	0.00135	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—DGKH—nephrolithiasis	0.000323	0.00135	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000315	0.00132	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CHRM3—nephrolithiasis	0.000308	0.00129	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—APRT—nephrolithiasis	0.000308	0.00129	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—SLC26A1—nephrolithiasis	0.000308	0.00129	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—CHRM3—nephrolithiasis	0.000307	0.00129	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—AGXT—nephrolithiasis	0.000295	0.00123	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PTH—nephrolithiasis	0.000282	0.00118	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—APRT—nephrolithiasis	0.000268	0.00112	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000268	0.00112	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—AQP1—nephrolithiasis	0.000259	0.00108	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—APRT—nephrolithiasis	0.00025	0.00105	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	0.00025	0.00105	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CHRM3—nephrolithiasis	0.000234	0.00098	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CHRM3—nephrolithiasis	0.000233	0.000977	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—AQP1—nephrolithiasis	0.000219	0.000918	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000218	0.000912	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PTH—nephrolithiasis	0.000213	0.000893	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CHRM3—nephrolithiasis	0.000198	0.00083	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000194	0.000813	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—AQP1—nephrolithiasis	0.000191	0.0008	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—SPP1—nephrolithiasis	0.000191	0.000799	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—AQP1—nephrolithiasis	0.000178	0.000747	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CHRM3—nephrolithiasis	0.000173	0.000723	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—SPP1—nephrolithiasis	0.000167	0.0007	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000165	0.000691	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000165	0.000691	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CHRM3—nephrolithiasis	0.000161	0.000676	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—SPP1—nephrolithiasis	0.000141	0.000592	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—AQP1—nephrolithiasis	0.000118	0.000493	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SPP1—nephrolithiasis	0.000107	0.000449	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CHRM3—nephrolithiasis	0.000106	0.000446	CbGpPWpGaD
